Bayer – Global Home
As a global company with core competencies in health care and agriculture, we design our products and services to address the world´s greatest challenges and the most fundamental human needs.
Pharmaceuticals | Bayer | Bayer Global
Sep 16, 2024 · As a leading healthcare company, Bayer offers innovative solutions for the prevention, alleviation and treatment of diseases. Bayer's Pharmaceuticals Division focuses on prescription products for women's health, cardiology, oncology, hematology and ophthalmology.
Health for all, Hunger for none | Bayer United States
At Bayer, our commitment is to better the lives of all Americans – we’re finding groundbreaking solutions that help put food on our tables and offer innovations in self-care and medicine for all Americans so they can live better lives.
Careers | Bayer USA | Bayer United States
Aug 15, 2024 · Because we’re a pioneer in the fields of human, and plant health. Because we invent the solutions that will create a sustainable future for our planet. Because a career with Bayer means you can put your passion into practice and make an impact.
Bayer Consumer Health | Bayer United States
Apr 17, 2024 · It has been our mission to help people manage their personal health for more than 120 years. Today, we continue that mission by producing some of the world’s most trusted pain relievers, allergy medications and dietary supplements that continue to …
Bayer’s Pharma Growth Strategy Progressing Well as Pipeline …
5 days ago · WHIPPANY, N.J., January 14, 2025--On the occasion of the 43rd J.P. Morgan Healthcare Conference in San Francisco, Bayer AG announces further progress in its pharmaceutical growth strategy with ...
Commitment to Advancing Health for All | Bayer United States
America’s health challenges are always evolving—and no one can address them alone. At Bayer, we collaborate with the best and brightest minds who share our passion for advancing standards of care to address critical unmet healthcare needs across the United States.
Bayer’s Pharma Growth Strategy Progressing Well as Pipeline …
6 days ago · With regulatory submissions under review around the world, Bayer anticipates a potential launch this year, aiming for fast market penetration building on Bayer's strength in women's healthcare. Elinzanetant is the first dual neurokinin-1 and 3 (NK-1 and 3) receptor antagonist with potential to transform the management of menopause, broadening ...
Bayer’s Pharma Growth Strategy Progressing Well as Pipeline …
5 days ago · WHIPPANY, N.J., January 14, 2025 – On the occasion of the 43rd J.P. Morgan Healthcare Conference in San Francisco, Bayer AG announces further progress in its pharmaceutical growth strategy with multiple regulatory filing submissions underway for key growth drivers darolutamide, finerenone, and elinzanetant. "We are successfully delivering on our ambitious business goals despite significant ...
Bayer - Wikipedia
Bayer AG (English: / ˈbaɪ.ər /, commonly pronounced / ˈbeɪər /; [3] German: [ˈbaɪɐ]) is a German multinational pharmaceutical and biotechnology company and is one of the largest pharmaceutical companies and biomedical companies in the world.